Brenda O'Connell

2PUBLICATIONS
16CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 30, 2024
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment.

Brenda C O'Connell, Charley Hubbard, Nora Zizlsperger

|Mar 31, 2023
Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial.

David S Hong, Michael Postow, Bartosz Chmielowski

Pageof 1

Frequent Collaborators

1 joint publications

David S Hong

1 joint publications

Michael Postow

1 joint publications

Bartosz Chmielowski

1 joint publications

Ryan Sullivan